Axial Biotherapeutics scores $10 mln
Axial Biotherapeutics, a developer of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, has secured $10 million in funding. The backer was Taiho Ventures LLC.
20 June 2019•1 min read
